Cerecor Inc.

http://www.cerecor.com/

Last activity: 02.08.2021

Active - Reference to Avalo Therapeutics

Categories: DevelopmentDrugIndustryInterest

Facebook

Mentions

Overview

Employees

11-50

Total raised

$38.8M

Founded date

2011

Investors 3

Date	Name	Website
Sign up to see	Sign up to see	Sign up to see
	Puget Sound Venture Club	pugetsoundvc.com
Nov 6, 2022	Hercules Capital	htgc.com

Funding Rounds 2

Date	Series	Amount	Investors
Sign up to see	Sign up to see	Sign up to see	Sign up to see
Sep 12, 2013	Funding round	$6.8M

Mentions in press and media 20

Date	Title	Description
Sign up to see	Sign up to see	Sign up to see
Aug 2, 2021	Cerecor Inc. Announces Drawdown of $10 Million Tranche Under Its Debt Financing Agreement with Horizon Technology Finance	Cerecor Inc. announced that it has completed its second drawdown of $10 million under its previously announced $35 million debt financing agreement with Horizon Technology Finance Corporation. With the closing of the second tranche, the Com...
Jun 8, 2021	CERECOR INC. Cerecor : Enters Into $35 Million Debt Financing Agreement With Horizon Technology Finance (Form 8-K)	Cerecor Enters Into $35 Million Debt Financing Agreement With Horizon Technology Finance •An initial tranche of $20 million drawn at the loan closing •Funds ongoing clinical development of key investigational product candidates •Financing p...
Jun 7, 2021	CERECOR INC. Cerecor Enters Into $35 Million Debt Financing Agreement With Horizon Technology Finance	An initial tranche of $20 million drawn at the loan closing Funds ongoing clinical development of key investigational product candidatesFinancing provides flexibility and extends runway through multiple clinical catalysts expected in 2021 R...
Dec 10, 2020	News briefing: Trial software firm ERT merges with imaging company Bioclinica; AbCellera bumps IPO range	ERT, an enterprise software and consulting firm that sells platforms to run elements of clinical trials, has bought a new company in order to boost its imaging capabilities. The business is acquiring Bioclinica for ...
Sep 27, 2018	Biopharmaceutical firm Cerecor plans to relocate HQ from Baltimore to Rockville	Cerecor, a publicly traded biopharmaceutical company developing treatments for orphan disorders, is planning to relocate from Baltimore city to Rockville, Md. According to documents filed with the U.S. Securities and Exchange Commission, th...
Sep 25, 2018	Cerecor acquires New York biopharmaceutical company for $26.6M in stock	Baltimore-based Cerecor announced the acquisition of Ichorion Therapeutics, a New York–based biopharmaceutical company. The deal includes an all-stock transaction worth up to $26.6 million, with potential for an additional $15 million in mi...
Sep 17, 2018	Here’s a look at Maryland’s publicly-traded biotech companies	When talk turns to Maryland’s biotech bonafides, the ideas and talent being produced by government institutions like NIH, and research-oriented universities with connected health systems such as Johns Hopkins and University of Maryland are ...
Mar 29, 2018	Amgen vet Marc de Garidel takes the helm at Corvidia; Peter Greenleaf lands next CEO job at Cerecor; Edward Gudaitis tapped to lead Acerus	→ Amgen vet Marc de Garidel is taking the helm at Corvidia Therapeutics as the biotech wraps up a Phase II trial of its personalized therapy for chronic kidney disease. Michael Davidson, the founding CEO who designed the s...
Nov 30, 2016	Fresh enthusiasm for Cerecor sours as lead drug flops in PhII depression study, shares crater	Uli Hacksell, Cerecor A few weeks ago, investors embraced shares of Cerecor in the big surge that swept up Alkermes’ stock following its clinical success for an anti-depression drug that bore some striking resemblances to ...
May 4, 2016	How ketamine eases depression — and why that matters for the drug industry	A promising experimental antidepressant may work differently than scientists had previously thought, potentially explaining multiple failed drug trials over the past decade. Ketamine has been known since the turn of the millennium to have p...
Mar 4, 2015	Section1 is planning a crowdfunding campaign [Startup Roundup]	WHO’S MAKING MOVES DreamIt Health Baltimore named Shervonne Cherry as Program Manager. Cherry moved to the accelerator following a long stint with Mindgrub, most recently as creative and social strategy lead. In her new role, she will be ma...
Jul 23, 2014	Neuroscience drugmaker raises $16.3M [Startup Roundup]	Who’s getting funded? Downtown biotech startup Cerecor pulled in more than $16.25 million in equity and debt funding in a Series B round, according to an SEC filing. The fundraising was out of a $33.25 million offering. The neuroscience dru...
Jul 22, 2014	Cerecor halfway through $32M Series B, developing “Special K”-like med for severe depression	Cerecor’s compound improves upon ketamine’s shown efficacy, CEO Blake Paterson said, working on the NMDA pathways in a similar manner – but with an improved safety profile. “We want to see if we can reproduce the ketamine high, and see what...
Jul 21, 2014	Cerecor Closes on $16.25M Tranche of Series B	BALTIMORE, MD, Biopharmaceutical company developing innovative treatments to make a difference in the lives of patients suffering from nervous system disorders, today announced the closing of the first tranche of a $32M Series B financing...
Jul 21, 2014	Cerecor Closes First Tranche of $32M Series B Financing	Cerecor Inc., a Baltimore, MD-based clinical stage biopharmaceutical company developing treatments for patients suffering from nervous system disorders, closed the first tranche of a $32m Series B financing. The round was led by New Enterpr...
Sep 12, 2013	Cerecor Closes $6.8M Series A1 Financing	Cerecor, Inc., a Baltimore, MD-based biopharmaceutical company developing neuroscience drugs, closed a $6.8m Series A-1 financing. The company intends to use the funds to provide working capital to complete the acquisition and technology tr...
Sep 11, 2013	Cerecor biopharmaceuticals raises $6.8M in equity [Startup Roundup]	Have news for the Startup Roundup? Get in touch.who’s getting funded? Cerecor Inc., based in Canton, has raised $6.8 million in equity, according to SEC filings. The biopharmaceutical company “focused on the discovery, development and comme...
Mar 4, 2013	InvestMaryland Challenge: 33 semi-finalists head to final round to vie for $100K prize	Of a total 259 startups that applied to the InvestMaryland Challenge, just 33 will be given a chance tomorrow to be one of three winners of $100,000 in funding. As Technically Baltimore has reported, the challenge is the inaugural, early-st...
	Cerecor halfway through $32M Series B, developing “Special K”-like med for severe depression	Baltimore-based Cerecor has a fast-tracked, fast-acting drug called CER-301 that treats those with severe major depressive disorder and suicidal tendencies. And it works a little like ketamine, the anesthetic-turned-illicit party drug-turne...

Reviews 0

FAQ about Cerecor Inc.

When was Cerecor Inc. founded?

Cerecor Inc. was founded in 2011.

How much funding has Cerecor Inc. raised?

Cerecor Inc. has raised $38.8M in total across 2 funding rounds.

What funding rounds has Cerecor Inc. raised?

Parsers VC lists 2 funding rounds of Cerecor Inc., among them a funding round of $6.8M on Sep 12, 2013.

Who has invested in Cerecor Inc.?

Parsers VC lists 3 investors of Cerecor Inc., among them Hercules Capital and Puget Sound Venture Club.

What has the press written about Cerecor Inc.?

Parsers VC has collected 20 articles mentioning Cerecor Inc., among them “Cerecor Inc. Announces Drawdown of $10 Million Tranche Under Its Debt Financing Agreement with Horizon Technology Finance” (Aug 2, 2021) and “CERECOR INC. Cerecor : Enters Into $35 Million Debt Financing Agreement With Horizon Technology Finance (Form 8-K)” (Jun 8, 2021).

Is Cerecor Inc. still active?

Yes, Cerecor Inc. is active; its latest activity on Parsers VC dates from Aug 2, 2021.